Summary of Bad Blood by John Carreyrou

Bad Blood is John Carreyrou's investigative account of Theranos, the Silicon Valley startup founded by Elizabeth Holmes that promised to revolutionize blood testing with a single drop of blood. Despite reaching a $9 billion valuation, the company's technology never worked as promised, leading to one of the biggest corporate frauds in recent history.

Key Concepts

Vision vs. Reality

Holmes promised revolutionary blood testing technology that could run hundreds of tests from a finger prick
Scientific reality proved this was fundamentally flawed - minimum sample volumes are required for accurate results
Engineering failures included devices that clogged and produced inconsistent results

Silicon Valley Culture

"Fake it till you make it" mentality enabled deception to flourish
Hype and charismatic storytelling replaced scientific validation
Fear of missing out led investors to skip due diligence

Culture of Fear and Secrecy

Extreme confidentiality and employee surveillance suppressed internal criticism
Compartmentalized teams prevented collaboration and problem-solving
Whistleblowers faced legal intimidation and harassment

Fraudulent Practices

Staged fake demonstrations for investors and partners
Used traditional lab equipment while claiming results came from proprietary devices
Endangered patients with inaccurate test results

Downfall and Accountability

Whistleblowers and investigative journalism exposed the fraud
Regulatory investigations confirmed the deception
Holmes and COO Ramesh Balwani faced criminal charges

Carreyrou's account demonstrates that scientific truth cannot be replaced by vision or charisma, and that ethical accountability ultimately prevails over corporate deception.